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Abstract. Nanotechnology is giving us a glimpse into a nascent ﬁeld of nanopharmacology that deals with
pharmacological phenomena at molecular scale. This review presents our perspective on the use of
scanning probe microscopy techniques with special emphasis to multidimensional atomic force micro-
scopy (m-AFM) to explore this new ﬁeld with a particular emphasis to deﬁne targets, design therapeutics,
and track outcomes of molecular-scale pharmacological interactions. The approach will be to ﬁrst discuss
operating principles of m-AFM and provide representative examples of studies to understand human
health and disease at the molecular level and then to address different strategies in deﬁning target
macromolecules, screening potential drug candidates, developing and characterizing of drug delivery
systems, and monitoring target–drug interactions. Finally, we will discuss some future directions including
AFM tip-based parallel sensors integrated with other high-throughput technologies which could be a
powerful platform for drug discovery.
KEY WORDS: atomic force microscopy; drug discovery; multimodal AFM; nanopharmacology;
nanotherapeutics.
INTRODUCTION
Jonathan Swift’s Gulliver’s Travels, ﬁrst published in
1726, concerned, in part, his adventures after being ship-
wrecked and awakening as a prisoner of a tiny race of people
who inhabit the country of Lilliput. The authors of this review
(RL and MFA) have been having adventures together since
1991 in their own Lilliputian world of applying nanotechnol-
ogy to the biomedical science (1) using atomic force micro-
scopy (AFM). This review will focus on the application of
multidimensional atomic force microscope (m-AFM) to
nanopharmacology in deﬁning the structural targets for drug
action, in drug design and delivery systems, in monitoring
target–drug interaction and in tracking their outcomes at the
molecular level. We will begin this review with a brief
introduction to AFM principles, imaging modes, and their
unique advantages.
Operating Principle of AFM
Gerd Binnig and Heinrich Rohrer received the Nobel
Prize in physics in 1986 for inventing the scanning tunneling
microscope 5 years after describing the method. In 1986,
Binnig et al. (2) developed the atomic force microscope, a
technique that evolved into a series of scanning probe
microscopes. The genius of the approach for AFM, like other
related scanning probe microscopes, is that it uses the
physical interactions between a cantilevered probe (tip) and
the specimen for imaging as it scans over the specimen’s
features. A very sharp cantilevered tip passively senses the
localized interaction forces between the atoms of the scanning
tip and the specimen surface as either the tip or the specimen
is raster scanned in the x-y plane over its complement (tip or
sample). The raster scanning is accomplished either by
attaching the sample or the cantilevered tip itself to a scanner.
The cantilever is commonly made of silicon or silicon nitride,
although other materials can be used, and the radius of
curvature of the tip is in the order of nanometers. The
scanner consists of piezoelectric ceramic elements with a sub-
nanometer hardware resolution. The z (vertical) position of
the sample (or tip) is monitored by an electronic feedback
circuit that maintains a constant deﬂection, ensuring a
constant force of interaction between the cantilever tip and
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interaction force between the sample and the AFM probe.
The amount of z variation needed to maintain the interaction
force constant is plotted versus the x and y coordinate,
thereby producing a topographic image. Most commonly, the
cantilever deﬂection is monitored by bouncing a laser beam
on the back of the cantilever to a quadrant photodetector
which converts light signal into electrical signal (Fig. 1, top
left panel) that is fed to an electronic feedback circuit that
generate necessary voltage to the piezocrystal to maintain the
tip–specimen distance constant and hence follow the sample
surface contour to provide a 3D topographical image.
Tip–Sample Interaction Forces
When the cantilever tip approaches the sample surface,
the sum of the attractive and repulsive forces between them
determines the deﬂection of the cantilever in contact mode
and the damping of vibration amplitude in the tapping mode
(see “Imaging Modes” below). The overlapping of electron
orbitals between the atoms of the tip and the sample are the
dominant repulsive force sensed by the AFM cantilever. The
Van der Waals interaction is the dominant attractive force
sensed by the cantilever, which is primarily due to delocalized
dipole–dipole interactions (3). The meniscus surface force
that exists while imaging in air is another strong attractive
force. While imaging in ﬂuids, electrostatic interactions occur
between charges of sample and tip, and structural forces such
as hydration force, solvation forces, and adhesion forces also
come into play (4).
Torsional deﬂection of the AFM cantilever is used to
measure lateral forces (5) and could be used to generate
images containing information about the local surface chem-
istry, like separate lipid and protein clusters in a membrane.
In tapping mode, conductive/magnetically coated cantilevers
can sense electrostatic/magnetic forces and image, for
instance, magnetic domains, surface charge distributions, local
surface capacitance, and conductance. In principle, any signal
that is spatially resolved (x, y) and that is a function of
distance from the sample (z) can be made into a microscope
parameter.
Imaging Modes
The two most commonly employed imaging modes for
the AFM are the contact and tapping or vibration modes. In
the contact mode, an electronic feedback circuit maintains a
constant deﬂection, ensuring a constant force of interaction
between the cantilever tip and sample. The amount of z
variation required to maintain the interaction force constant
is plotted versus the x and y coordinate, thereby producing a
topographic image, although images may not be purely
topographical (see “Tip–Sample Interaction Forces” above).
In the tapping or vibration mode, the cantilever oscillates
up and down near its resonance frequency by a piezoelectric
element on the tip holder. The amplitude of cantilever
vibration is maintained constant during scanning by a feed-
back signal. The image is produced by plotting the displace-
ment of the sample relative to the base of the cantilever
necessary to keep the amplitude of the vibration constant.
The phase lag between the driving circuit and the actual tip
vibration is also measured and used for imaging physical
properties.
Spatial and Temporal Resolution
Since the interaction between the AFM tip and speci-
men is not limited by wavelength, molecular, and even
atomic resolution is possible. Spatial resolution depends on
the sensitivity of the piezoelectric scanner and may be as
high as 0.1 nm laterally and 0.01 nm vertically. Resolution
also depends on the size and shape of the probing tip as
well as on the material properties of the sample under
investigation. In general, the sharper the tip, the higher is
the resolution. To this end, we have been able to fabricate
the ﬁrst integrated cantilevered nanotip (Fig. 1, top right
panel) and were able to obtain both high-resolution
structural information as well as the electrical characteristics
simultaneously (6). Hard, crystalline samples can be imaged
with high resolution, and images with atomic and subatomic
features have been achieved (7). Structures <1 nm apart are
resolved on non-crystalline arrays (8). Biological samples
are soft, so resolution is less. Nevertheless, the resolution
can still be remarkable with soft specimens. For example,
AFM studies on reconstituted ion channels can resolve the
substructure of channels and, at times, the subunits within
each channel. We, and others, have distinguished between
hexameric and pentameric connexons and have shown that
amyloid ion channels range from tetramers to octamers (9–
11).
Temporal resolution depends on the speed of the feed-
back electronics as well as the scan size of the specimen.
Examination of dynamic behavior requires higher scan
speeds. Improving temporal resolution is a rapidly evolving
area of AFM design. Current AFMs can image repeatedly
and reliably a small line or a point over a sample surface such
as a subunit of an ion channel or receptor in a millisecond, a
small area such as an ion channel or receptor in less than a
second, and an array of 20×20 channels in a second or two.
The new AFMs under development hold promise to improve
the temporal resolution by a factor of two or more in near
future.
Advantages of AFM
Important features of AFM include: (1) The physical
interaction that underlies AFM imaging is not constrained by
wavelength and, therefore, permits the resolution for molec-
ular and even atomic imaging. (2) AFM permits the 3D
imaging of surfaces and biomolecules with molecular and
submolecular resolution. (3) AFM does not require destruc-
tive pretreatment or imaging conditions such as occurs in
electron microscopy, nor does it require crystallization as
needed for high-resolution X-ray imaging that may affect
physiology. (4) AFM can image specimens in a physiologic
solution, thereby allowing the investigation of dynamic
processes involving molecules, organelles, and other struc-
tures in living cells. (5) AFM can be modiﬁed to serve as a
sensor of intermolecular interaction forces, charge, pH, and
other physicochemical properties. (6) AFM cantilever tips can
be functionalized chemically or biochemically to allow the
identiﬁcation of speciﬁc molecules and the measurement of
717 m-AFM: A Versatile Novel Technology for Nanopharmacology ResearchFig. 1. Multimodal AFM. Top left Operating principle of AFM. A cantilevered tip is scanned over the sample, maintaining constant force using
feedback control to keep cantilever deﬂection at constant amplitude. Cantilever deﬂection, in this example, is measured using an optical beam
deﬂection system. Top right Scanning electron microscope image of a microfabricated integrated nanotube cantilevered tip; inset shows the
nanometer-sized tip (adapted from Chen et al. (6)). Bottom Left A schematic diagram of the optical components of an AFM combined with a
light ﬂuorescence microscope. The optical focusing of the laser light is integrated within the piezotube which provides the lateral movement of
the cantilever. The scanning lens is located inside the lower segment, which provides the vertical movement of the cantilever. After the positions
of the lenses are adjusted, the scanning focused spot accurately tracks the cantilever, and the zero deﬂection signal from the four-segment
photodiode is independent of position within the scan area. The AFM is placed on the stage of an inverted microscope (adapted from Hansma et
al. (15)). Bottom right Internalization of small liposomes: light microscopy (a), ﬂuorescence (b), and tapping mode AFM (c–f) imaging of ﬁxed
cells at different time intervals after incubating with cisplatin-encapsulated liposomes. Height mode images (c, e) and error mode images (d, f)o f
the same cells. Error mode images show better contrast and ultrastructural details. The liposomal position with respect to the cell membrane was
determined from the height mode images. For cells incubated with cisplatin-encapsulated liposomes for only 1-h incubation sample, many large
liposomes are seen on the cell surface (red arrows in a–d). On the other hand, small cisplatin-encapsulated liposomes appear to be internalized
in the cell cytoplasm (black arrows in c, d). The inset in d shows a zoomed-in portion of the encircled area: the internalized liposomes are clusters
of small liposomes (white arrows) of ~250-nm diameter. After 16 h of incubation, no deﬁned liposomes were observed (e, f). Scan size of AFM
images is 25 μm, adapted from Ramachandran et al. (17)
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Precise physical manipulation of biomolecules, dissection of
biological structures and tissues, delivery of drugs, ligands,
and nanoparticles to speciﬁc locations, and the measurement
of interactions at speciﬁc sites are possible because of the
precise nanometer control of the position and the piconewton
control of the force of the cantilever. (8) The open
architecture of AFM apparatus allows integrating with other
complementary techniques, including conventional light and
ﬂuorescence microscopy, total internal reﬂection ﬂuorescence
(TIRF), Förster resonance energy transfer (FRET) micros-
copies, electrophysiology, opto-electronic manipulators, nano-
micro ﬂuidics, etc., to obtain complete structure–function
relationship of biomolecules/structures at molecular resolu-
tion in their native physiological environment. This ﬂexibility
makes it possible to convert the AFM into a powerful
multidimensional AFM (m-AFM) platform. (9) Very small
amounts of drug/reagents are required, which is an enormous
advantage in pharmacology where the molecules are often
quite precious.
AFM AND NANOPHARMACOLOGY
Nanopharmacology could be deﬁned as the application
of nanotechnologies for drug design and drug delivery to
selective molecular targets with improved pharmacodynamic
and kinetic proﬁles for safer and effective drug treatment.
This includes understanding the individual nanoscale molec-
ular targets for rational drug design, design, development,
and manufacture of nanoscale drug carriers like nanotubes,
nanoshells, nanospheres, etc., nanostructured materials for
drug storage and release in the body, and the ability to call
back the drug after its intended effect is achieved via
nanosponge, for example.
The importance of understanding pharmacological tar-
gets at their molecular level cannot be overemphasized for
the advancement of nanopharmacology. AFM by itself, or
along with other complementary techniques (m-AFM), would
enable investigators to understand the structure–function of
both the targets and effectors (drugs) at their molecular scale.
For the sake of simplicity and clarity, applications of AFM
techniques in nanopharmacology will be categorized broadly
into the following sections for this review:
1. Deﬁning targets
2. Development of drugs and carrier systems
3. Studying target–drug interactions
4. Monitoring the target–drug interaction outcomes and
5. Future directions
MULTIMODAL AFM FOR DEFINING TARGETS
Identiﬁcation of features on biological samples can be
difﬁcult since many features look very similar at very high
resolutions (<100 nm). One approach has been to use well-
deﬁned and highly puriﬁed biological materials, such as gap
junctions or reconstituted ion channel proteins and receptors
as studied in (9,10,12). Another approach has been to use
complementary molecules for proper identiﬁcation. A power-
ful feature of the AFM is that the cantilever tip can be
functionalized to react very speciﬁcally with a target mole-
cule. For example, linking of speciﬁc antibodies to the tip via
a spacer allows the recognition of its antigen on the surface of
a specimen (13,14). Such images reﬂect both topography and
the strength of interaction between the antibody on the AFM
tip and the antigen on the sample. Multimodal imaging also
provides an approach for the direct conﬁrmation of structural
identity, such as combining AFM imaging with other techniques
such as ﬂuorescence microscopy that provides complementary
information speciﬁc to each target.
AFM Combined with Optical Microscopy
As mentioned before, multimodal imaging provides an
approach for the direct conﬁrmation of targets being imaged
by AFM by various optical microscopy techniques through
ﬂuorescent labeling. The open architecture of AFM allows
such integration, and, as shown in Fig. 1 (bottom left), the
AFM has been integrated with optical microscopy. Since its
adaptation (15), simultaneous ﬂuorescence and AFM imaging
has been used to study complex biological systems, including
cells cultured on Petri dishes (16). The approach has been
used to link changes in cell mechanical properties, assessed by
AFM, to the functionality of hemichannels, determined by
ﬂuorescence. Similar approaches could be utilized for study-
ing the effect of drugs on cells/targets. Figure 1 (bottom right
panel) shows a compelling evidence of multimodal imaging
application for nanopharmacology. Cisplatin-encapsulated
liposomes are imaged to show their real-time uptake by cells
in culture by ﬂuorescence as well as by AFM. Signiﬁcantly,
cells allowing the uptake of liposomes containing cisplatin did
not survive. AFM imaging revealed that smaller liposome’s
(<200 nm) were effectively internalized by cells compared to
larger preparations (17).
AFM Combined with Tools to Assay Ion Conductance
or Permeability
Another powerful application of m-AFM is combining
imaging with the assessment of physiologic function, which
could be used for target identiﬁcation. An example of a
combined AFM and ion conductance measurement system is
the one ﬁrst developed by Proksch et al. (18) in which a few-
nanometer-thick glass electrode serves two purposes. First, it
acts like an AFM cantilever tip and, second, acts as a
nanoelectrode for recording ion conductance across a bilayer
or a cell membrane. Using this system on a synthetic
membrane ﬁlter (nucleopore membrane), conductance
through 200-nm pores was measured when a potential differ-
ence was applied. Such an approach allow identifying
molecular targets in unstained cells/tissue, which is otherwise
impossible with conventional techniques at a single molecular
level.
As an extension of such a combined AFM and ion
conductance measuring system, AFM has recently been
combined with an advanced nanochip-supported, double-
chamber permeability and transport assay system (Electronic
Supplementary Material (ESM) Fig. S1). This combined
system allows studying the activity of ion channels and pores
and would facilitate high-throughput screening of channel
activity modiﬁers and thus would be a valuable tool for
developing therapeutics for channelopathies. ESM Fig. S1
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is measured for ion channels formed by gramicidin that
have been reconstituted in a lipid bilayer supported over
an ~70-nm diameter nanopore in a silicon chip. Gramicidin
is a complex mixture of linear polypeptide antibiotics
produced by Bacillus brevis that induces ion channel-like
activity when in contact with the cell membrane and is a
good test structure for deﬁning membrane permeability
and transport. In the same setup, images of the nanopore
and bilayer were also imaged with the AFM. Signiﬁcantly,
this study also shows that the AFM imaging force is soft
enough to image delicate and fragile biological membranes
that could be used for identifying targets.
AFM tips can be made conductive that would allow
studying the conformational changes in ion channels, as
would occur in response to ligands and other therapeutics.
It can also be used for characterizing many advanced
materials with wide biomedical applications. Using this
conducting AFM, Ionescu-Zanetti et al.( 19) obtained the
direct structure–function analysis of conjugated polymer
blends. Polymer blends have wide biological applications,
including micro-actuators (20), chemical sensors (21), and
light-emitting diodes (22). Optically and electrically conju-
gated polymer blends are currently being tested for their
potential application in deﬁning pathological markers and for
the targeted delivery of therapeutics.
AFM FOR TARGET IDENTIFICATION: IMAGING ION
CHANNELS AND DEFINING CHANNELOPATHIES
Conventional Channelopathies
Traditionally, channelopathies are considered to have an
altered structure and/or function of ion channels. A long and
rapidly increasing list of diseases fall into this category, such
as the long QT syndrome and its associated potentially lethal
arrhythmias that involve mutations in sodium and potassium
channels, myotonia congenita involving voltage-dependent
chloride channels, some forms of retinitis pigmentosa that
involve non-speciﬁc ligand-gated channels, cystic ﬁbrosis with
defective chloride channel, and a long list of other diseases
(23). m-AFM would be an ideal and indispensable platform
to study and understand the pathogenesis of these disorders
(9,10). An example of the potential application of AFM to
conventional channelopathies mediated by gap junctions and
hemichannels is provided below.
Gap Junctions and Hemichannels
Many years ago, we described the use of what we termed
“force dissection,” which is the application of force with the
cantilever to expose heretofore inaccessible surfaces. Using
this approach, we dissected gap junctions, exposing both the
extracellular and cytoplasmic faces of the gap junctions,
which could then be imaged (1). In the earlier years of
collaboration, we also assessed the electrophysiologic charac-
teristics of gap junctions (24). One of us in the early 1990s
called AFM the “dream machine.” We dreamed of measuring
conductances while imaging came into being, and now, m-
AFM can potentially make the dream come true.
Hemiplaques and hemichannels are non-junctional con-
nexons that are composed of connexin hexamer. In 1995, we
observed what we believed were hemiplaques or hemi-
channels in heart gap junction preparations, but could only
speculate on their function (25). There is increasing evidence
that hemichannels are involved in cell volume regulation and
in programmed cell death (26).
Hemichannels have more recently been imaged in lipid
bilayers after reconstitution in liposomes (11). A distinct
difference was observed between two populations of channel-
like structures that correspond to the extracellular and
cytoplasmic side of the hemichannels Furthermore, by
changing calcium levels in the imaging buffer, hemichannels
could be imaged both in their open (low calcium) and closed
(normal calcium) state with sub-nanometer resolution (Fig. 2,
bottom panel). Using phase imaging, where the phase lag
between the tip oscillation in tapping mode and the driving
signal is monitored, (11) and surface energy measurements
using AFM, a spike in the phase signal of open channels was
observed, most likely due to the exposed hydrophobic
domains of the hemichannel in open state.
Signiﬁcantly, these open hemichannels are known to
regulate isosmotic cell volume and cell mechanics for normal
tissue growth (16) and are known to facilitate external
oxidative stress signal to induce apoptosis, as would occur in
response to environmental stress and lifestyle (e.g., smoking)
choices (27,28). Thus, m-AFM has been used to deﬁne
molecular targets in health and disease (Fig. 2, bottom panel).
Similar approach could be used to reveal novel targets in our
pursuit of understanding human health and disease.
Channelopathies Mediated by Ion Channels Formed
from Misfolded Proteins
We now turn to what we believe is a true paradigm shift.
The ability of the AFM to image with high resolution has led
to a paradigm shift in amyloidogenic diseases and holds
promise to do the same for a number of other diseases.
Misfolded proteins can form channels in the cellular mem-
branes and alter ionic homeostasis, which can cause stress and
injury to electrically sensitive cells in the body, including for
example cardiomyocytes, neurons, and muscle cells. This
mechanism has opened an exciting new approach to the
understanding of these diseases.
A series of AFM studies of many amyloids, including
amyloid beta protein, amylin, alpha-synuclein, ADan, ABri,
and serum amyloid A, revealed ion channel-like structures
that show single ion channel activity when reconstituted in
membranes (Fig. 2, top left panels)( 10,29). The resolution of
AFM images has been sufﬁcient to resolve the channel
structure and distinguish different subunit arrangements.
Electrical recording from these preparations show that these
amyloid channels are active and conduct ionic currents (Fig. 2,
top right panels). Cell calcium loading and cell degeneration
studies showed that these amyloids induce a pathological
response via their ion channel formation, a ﬁnding that
provides a paradigm shifting perspective of amyloid-dependent
pathologies. The pathogenetic mechanism of amyloidosis, at
least in part, involves the creation of new channels that allow
the toxic ﬂow of ions. These diseases that form channels are
not really covered by the classic concept of channelopathies.
720 Lal, Ramachandran and ArnsdorfYet, with the apparent similarity, we consider them to be
“channelopathies of misfolded proteins.”
In deﬁning a speciﬁc structural substrate (ion channels
vs.u n d e ﬁned features such as plaques and non-ﬁbrillar
intermediates), AFM provides a structural basis for under-
standing the mechanistic details of neurodegenerative (e.g.,
Alzheimer’s disease, Parkinson’s disease) and systemic (e.g.,
diabetes, cancer, heart disease) diseases and for designing
drugs and therapeutic evaluations—m-AFM is a versatile tool
to study the high-resolution structures of these toxic ion
channels and could provide a technology platform for screen-
ing potential drug candidates for treating these diseases by
monitoring their action under real time with structural
evidence.
M-AFM FOR DRUG DISCOVERY AND DELIVERY
SYSTEMS
AFM Cantilever-Based Parallel Array of Sensors for Drug
Screening
Emerging technologies are generating AFM cantilever-
based array sensors being utilized for many purposes ranging
from high-throughput screening of genetic materials to the
identiﬁcation of individual protein/peptides that rely on speciﬁc
interactions using antibodies and peptides labeled with ﬂuo-
rescencemarkers.Forassayingdrugsfor“channelopathies”and
for identifying biomarkers of diseases, two powerful avenues
involve patch clamp(s) on chips and microﬂuidics. Signiﬁcantly,
Fig. 2. Top left panels Imaging single amyloid channels and hemichannels. Amyloid β( 1 - 4 0 ) ,A m y l i n ,A B r i ,A D a n ,σ-synuclein, and serum amyloid A
all show structures resembling ion channels after reconstitution in lipid bilayer and top right panels (a–f) show single ion channel activity as indicated by
parallel electrical recording.For details, see Quist et al. (10). Bottom panels Imaging open–closed conformation of hemichannels.Bottomleft panelshows
3D molecular topography of a single Cx43 hemichannel with six subunits and a closed central pore. Bottom right panel shows the open conformation of
the same hemichannel when the calcium concentration was reduced in the imaging media. A clear open pore is visible. For details, see Thimm et al. (11).
These open hemichannels allow the direct uptake of oxidative stress-inducing molecules and cell apoptosis (Ramachandran et al. (27)
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techniques easily and thus provide powerful screening/diagnos-
tic platform.
Patch Clamp on a Chip
Patch clamp recording is one of the main techniques
employed in electrophysiological studies and commonly used
in the study of channelopathies (30,31,32). The technique,
however, is slow with low throughput, making it undesirable
for use in drug discovery; an automated patch clamp that uses
disposable devices would be a most useful outcome. An
example of such an on-chip microchannel planar patch clamp
is shown in ESM Fig. S2. The middle panels show a HeLa cell
in the micro-ﬂuidic system and being trapped at one of the
channels. Cell deformation can be observed, and current
traces show a seal resistance of 144 MΩ (30). Such devices
using a cell reservoir linked to patch channels allows for the
simultaneous optical and electrical recording which will
facilitate studying the role of ion channels with respect to
cellular functions. Future devices can be designed with an
improved patch pore geometry and surface treatment to
obtain a better seal necessary for single-channel conductance
studies. Since the cell reservoir is linked to many patch clamp
pores, a parallel readout is possible, analyzing multiple cells
simultaneously. Also, there are many new variations of this
technique commonly being developed, the most important
being an array of patch clamping on nanochips with
integrated microﬂuidics.
Microﬂuidic Viscosity, Velocity, and Molecular Affinity
Sensors
Parallel readout techniques based on AFM cantilever
arrays allow for the analysis of several analytes with exquisite
intermolecular interaction sensitivity. When combined with
micro- (and nano-) ﬂuidic chambers, these array nanosensors
become high-throughput screening devices for biomarkers
and therapeutic agents. They can probe for instance multiple
live cells for their elastic properties or the presence of targets
in the cell membrane. Similarly, coating a parallel array of
cantilever with a different material or reagent on each lever
results in a “chemical nose” that can sense a variety of
chemicals or toxins in very small volumes.
Figure 3 (Top left and right panels) shows the schematics
of cantilevered microﬂuidic sensing tools in which a piezo-
electric cantilever senses the viscosity and velocity of ﬂuids
with different compositions at extremely small volumes. Such
a device can be easily adapted for screening biomarkers in
blood and body ﬂuids (Fig. 3, bottom panel). When combined
with local ﬂuorescence sensors (e.g., SPR, photo-sensitive
nanoparticles), electrical sensors (e.g., piezoelectric circuitry),
and mechanical sensors (e.g., cantilever deﬂection), an array
of cantilevers with speciﬁc complements can provide a
powerful and highly sensitive tool for high-throughput screen-
ing of pathologies and therapeutics. This scheme would allow
the identiﬁcation of an array of biomarkers and potential
drug candidate molecules from a very small (micro- to
milliliter) amount of bioﬂuid.
Cell Mechanics
Regulated biochemical processes as well as cytoskeletal
structural integrity play important roles in cell growth,
migration, and development (33). The local mechanical
properties of a cell are closely associated with biochemical
gradients across the membrane, but most techniques that
have been used to study single cells averaged over the entire
cell. AFM allows the measurement of mechanical properties
of cells and portions of cells with high spatial resolution. For
instance, rat atrial myocytes were imaged showing clearly the
cytoskeletal network beneath the cell membrane and myoﬁ-
brillar structure (34). Using a constant cantilever deﬂection
maintained by feedback, contractile activity, and the change
in contractile activity using perturbations in the buffer
environment (Fig. 4), cell stiffness was examined. Different
cantilever deﬂections were observed under different buffer
conditions for the same imaging force. This demonstrates the
possibility to quantify the coupling between extracellular
substrates to cellular functions such as contraction, migration,
growth, and differentiation.
Such monitoring of cell mechanics can be used effectively
tomonitortheefﬁcacyoftherapeuticsthatisexpectedtocorrect
abnormal cell mechanics. For example, the efﬁcacy of novel
inotropes, chronotropes on cardiac myocytes, endothelial bar-
rier function (34,35), etc., could be assessed at single cell with
high spatial resolution, thus serving a good drug screening tool
as well as assessing the efﬁcacy of a candidate drug.
Tissue Nanoelasticity and Nanopatterning
Nanomechanical properties of tissues depend on under-
lying ultrastructure of their constituents. A detailed under-
standing of tissue elasticity can be used for the early diagnosis
and for monitoring the disease progression and their treat-
ment outcomes, especially diseases of bones and joints.
Indeed, there are some new diagnostic tools being tested to
diagnose bone diseases (36,37) that resulted from our under-
standing of the tissue mechanics at the molecular level (38).
The correlation between the mechanical properties and the
heterogeneous subunits on a nanoscale has been limited.
Using AFM, such correlation studies are possible (39), as
shown in ESM Fig. S3.
AFM has been able to show the features of a cross-
sectioned wool ﬁber with similar amount of detail as TEM
(ESMFig.S3,leftpanels).Tostudythemechanicalpropertiesof
the different constituents of the ﬁbers, AFM force mapping has
been used. The force curves give information about the stiffness
and elastic modulus of the sample regions. For instance, it was
shown that the exo-cuticle part of wool ﬁbers has the highest
elastic modulus (19.8 GPa), while the endo-cuticle and cortical
regions of the ﬁber cross-section have signiﬁcantly lower
modulus (3.8 and4.0GPa, respectively).The indentations made
by a diamond tipped cantilever, all made with the same
indentation force, look indeed distinctly different for the differ-
ent regions (ESM Fig. S3, right panel). Furthermore, the AFM
can give conclusive evidence of the roleof disulﬁde bonds in the
ﬁber stiffness. Reduction of such bonds, abundant in the exo-
cuticle,usingdithiothreitol,resultedinareductionofmodulusto
0.3 GPa (39). This has shed new light on the role of the exo-
cuticle (small in mass proportion) to the rigidity of wool ﬁbers.
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pharmacology? Using the unique feature of deﬁned nano-
indentation, the compactness of drug molecules in a pellet,
which is critical for their release kinetics in body ﬂuids,
could be used as a quality control measure in drug
preparations. Signiﬁcantly, such nanopatterned features
would be helpful for creating security watermarks to ﬁght
the counterfeit drugs.
AFM for Drug Delivery
Targeted delivery of therapeutics has long been an ideal,
and a number of different approaches have been tried in the
past. Ideally, therapy could be efﬁcient if selective delivery of
drugs to the diseased tissue is achieved. Current bulk delivery
of drugs by oral or parenteral routes is inefﬁcient since this
requires a larger dosage and often has deleterious side effects.
Advanced molecular dynamic simulations and nanostructured
materials are providing new avenues for drug discovery and
delivery systems. Several nanoscale carrier systems, including
nanotubes, nanoshells, nanoliposomes, and dendrimers, are
being evaluated for effective and targeted delivery. These
carriers are designed to contain target guidance molecules
that are speciﬁc to cell/tissue surface.
AFM allows the design, characterization, and quality
control of these carriers. Integrated multimodal AFM also
allows imaging real-time transport of these carriers with
speciﬁc drugs and their effect on cells (17). One such
Fig. 3. Nanosensors for biomarkers and therapeutic agents. Top left panel Schematics of cantilevered
microﬂuidic sensor. Setup of the stainless steel needle. The cantilever is inserted and aligned using a
micromanipulator and held with the base nearly touching the upper edge of the channel opening. Middle
left panel FIB-milled cantilevers serve as ﬂow and viscosity sensors for biological ﬂuids. Top right panel
Comparison of voltage readout at different ﬂow speeds. High-viscosity ﬂuids such as ethylene glycol
saturate the ampliﬁer at relatively low ﬂow speeds. At higher ﬂow speeds, the sensor distinguished
between DMEM media with 5% and 50% fetal bovine serum. The protein content of blood serum is a
major contributor to the viscosity of biological ﬂuids. For details, see Quist et al. (62). Bottom panel
Cantilever-based array detectors for complements and biomarkers assay in a microﬂuidic chamber
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nanocarriers is shown in (Fig. 1). Small cisplatin-encapsulated
liposomes (<200 nm) are effective in killing cells due to their
efﬁcient internalization by cell endocytosis. An AFM-ﬂuores-
cence microscopy study was able to demonstrate that the most
effective liposomes that were able to deliver optimal dosage for
cell toxicity are those with a diameter of 100–150 nm. Much
smaller liposomes were unable to contain sufﬁcient amount of
cisplatin to induce toxicity, and larger liposomes were unstable
and not internalized by the cells efﬁciently.
Recently, cell-penetrating peptides, includingTAT peptide,
have been used to deliver various nano-particular pharmaceut-
ical carriers including liposomes, micelles, and nanoparticles
(40,41). Nanocarrier systems incorporated with stimuli-sensitive
properties are being developed. These stimuli may include pH,
temperature, and redox potential. Even carbon nanotubes ﬁlled
with a chemotherapeutic agent are being developed for the
treatment of tumors (42). These and other nanomedicinals will
likely use m-AFM in design, imaging, assessing pharmacologic
design, targeting, measuring interactions, and the like.
ASSESSING TARGET–DRUG INTERACTIONS: AFM
NANOSENSING
Multimodal AFM allows us to deﬁne targets, such as
channels,receptors,etc.,andtheirfunctionalactivity.Theability
to modify the cantilevered tip biochemically adds another
dimension to the versatility of the m-AFM techniques. By
suitable modiﬁcation of the tip, one could get a wealth of
information about intermolecular interactions at the single
molecular level (nanosensing). Attaching a drug molecule
directly or indirectly through spacers to the tip will allow
studying selective and speciﬁc interaction between the target
under investigation and the drug molecule. This will be an
indispensable tool in drug design and development. Here, we
highlight some of the examples where this approach has been
adopted to understand intermolecular interactions in our lab.
Structure, Density, Distribution, and Functional Viability
of Membrane Receptors and Channels
Rational drug design should consider the potential bio-
logical targets of drugs. As mentioned throughout this review,
channels, receptors, and other nanoscale structures are smaller
than the current resolution of light microscopic imaging.
Electron microscopy and other types of high-resolution imaging
cannot be used for live imaging, and hence, their utility is
limited. m-AFM, however, withdraws the resolution veil and
allows us to see new structures and new dynamic processes in
the Lilliputian nanopharmacological world.
In one of the earliest example of AFM mapping of cell
membrane receptors, the AFM was used to identify individual
nicotinic acetylcholine receptor (nAchR) that was expressed in
Xenopus oocytes (12). The structure was determined without
ﬁxationorotherpreparationsthatmightdenaturethesample,as
is often required for EM and other comparable imaging
techniques. The density, distribution, clustering, and functional
viability of these AChR receptors were conﬁrmed by other
relevant techniques, including channel conductance measure-
ments and ligand binding assays (ESM Fig. S4). Using ion
conductance microscopy (43) and intermolecular force mapping
(44–47) (see below) capability, m-AFM can provide density,
distribution, clustering, and functional viability of most of the
cell membrane channels/pores.
The possibility of linking molecules to the probing tip
provides a range of options to probe molecular interactions
between the probe on the AFM cantilever and the sample
surface (48,49,50). In this way, membrane proteins can be
probed on living cells. Using such modiﬁed and function-
alized cantilevers, adhesion forces have been measured and
mapped between ligands and receptors on the surface of
living cells (ESM Fig. S5). Using force volume imaging
(13), regional distribution as well as ligand- or antibody-
induced clustering of VEGF receptors have been reported
(ESM Fig. S5)( 13). Unbinding forces of 60–70 pN were
observed, which could be reduced by competitive inhibition
using antibodies.
Force mapping can also be useful for volume measurement
on cells too spherical or weakly attached to the substrate
surface. Using m-AFM with ﬂuorescence microscopy, Quist et
al.( 16) have shown that volume regulation of several cell lines
occurs through hemichannels. The added beneﬁt of using force
mapping is that not only are data obtained with respect to
unbindingforces,but,simultaneouslywithimaging,onecanalso
map the stiffness of the cell membrane. The stiffness is obtained
by looking at the approach force distance curves in each pixel,
which results in an elasticity map. Almqvist et al.( 13) showed
Fig. 4. Local contractile activity of a beating atrial cell recorded with
AFMtipunder1.8mM(a)a n d5mM(b)calciumand4 mMbutanedione
monoxime with high calcium (c). For details, see Shroff et al. (34)
724 Lal, Ramachandran and Arnsdorfclustering ofreceptorsusingthis technique, and(16)s h o w e dt h e
cytoskeletal stiffness change induced by volume change in the
cell.
Intermolecular interaction force maps can be used to
deﬁne speciﬁc domains of an effector (e.g., channels and
receptors). In one such example, Liu et al.( 50)u s e dA F M
tip conjugated with antibodies speciﬁc to different regions
of a hemichannel peptide, connexin43 (Cx43), to map the
speciﬁc Cx43 epitopes that open and close the hemichannel
in response to changing calcium concentration in the
medium (ESM Fig. S6). The amount of force required to
unwind the peptide necessary for opening the channel
correlated with the mobility and folding of speciﬁc portions
of Cx43.
Similar approaches could be utilized to investigate a
candidate drug molecule against its target in terms of its
efﬁcacy, which would be a boon in drug screening, drug
design, as well as in monitoring their pharmacologic action.
MEASURING THERAPEUTIC EFFICACY-TRACKING
OUTCOMES
Most drugs have a tight therapeutic range; toxicities
arise due to variations in metabolism, clearance rate,
preexisting conditions, interactions with other drugs
(cross-reactivity) and idiosyncrasies, etc. Currently, the
therapeutic efﬁcacy of medications is determined by bulk
assays that have no molecular resolution. Molecular under-
standing of the drug–target interactions could provide
important insights into some of these issues. As discussed,
single molecules can be imaged routinely with AFM, and it
is quite feasible to use AFM or m-AFM to monitor real-
time molecular interactions. Here, we highlight some of the
key studies which utilized this approach, which could be of
great potential in tracking the outcomes following ther-
apeutic intervention.
An interesting example is the proteolysis of collagen
that has been observed using AFM (Fig. 5)( 51). Single
collagenase binding to collagen could be imaged and its
digestion was followed in real time. Signiﬁcantly, as shown
in panels b and c, very often, collagenase molecules would
bind to collagen and dissociate without cutting the collagen
molecule. At present, such processes are typically moni-
tored using SDS-PAGE, which gives little information
about the real-time activity and the 3D structural informa-
tion of the binding of the enzyme to its substrate. The
dissociation constant derived from single-molecule proteol-
ysis is similar to what is observed from the bulk assay, but
clearly not all molecules are cleaved. This is an important
issue, for example in a drug cocktail, as used in the
treatment of HIV/AIDs where the efﬁcacy of individual
molecules cannot be determined from bulk assay.
With the possibility of monitoring single molecules
comes the advantage of being able to manipulate the single
molecules as well. As described above (ESM Fig. S6), by
tethering antibodies to the AFM tip, and after bringing the tip
in contact with the sample of interest, the antigen in the
sample cannot only be detected but also unfolded, as
reported above. Using this approach, mechanistic details of
calcium-mediated opening/closing of Cx43 hemichannels
were identiﬁed using antibodies speciﬁc for different regions
of the Cx43 cytoplasmic tail. The precise estimate of the
energy needed to unfold (fold) and amount of stretch
(contraction) in the channel unfolding measured by AFM
shows the promises of using AFM for better measure of the
therapeutic efﬁcacy of drugs and pharmacological agents with
single-molecule resolution. For example, a similar approach
could be used to assess the efﬁcacies of channel blockers by
measuring their unbinding force.
A number of years ago, we used AFM to detect
microcrystals in synovial ﬂuid from patients with crystal-
induced arthritis (52). The study was undertaken to
develop a system of “ﬁngerprinting” microcrystals with
AFM, and, to a large extent, we succeeded. Some speci-
mens contained more than one type of crystal, while other
specimens contained microcrystals that were undetected by
polarized light microscopy and by transmission electron
microscopy. Crystallization is also important in nephroli-
thiasis and renal disease. AFM can also be used to study
the development of crystals which, in turn, could be a
system for assessing the effect of pharmacological inter-
vention (53–56).
Another example would be the use of AFM in studying
diseases of the bone. Paul Hansma, one of the pioneers in
AFM, and his colleagues, recently wrote a very interesting
paper on imaging of bone ultrastructure using atomic force
microscopy (57). They point out that bone is a “remarkable
natural nano-composite material.” They reviewed much of
the literature and indicate how little has been studied at the
nanoscale level while emphasizing the potential of the
approach of imaging of bone in a functional manner using
AFM.
Damage to and degeneration of cellular and subcel-
lular elements is a common pathophysiological feature in a
variety of diseases. For example, the loss of synapses and
dendrites with eventual neurite degeneration characterize
several neurodegenerative diseases. AFM can be used to
image and track changes in cellular and subcellular
morphology. This, especially if combined with a ﬂuores-
cence or confocal microscope, gives the opportunity to
track changes in the cellular morphology and function
induced by various perturbations. For instance, amyloid
beta protein-induced changes in endothelial cells were
tracked (9)( E S MF i g .S 7). Since AFM can operate under
biological liquid environments, reagents can be added and
the physiologic solutions changed during imaging. In this
way, the therapeutic capability of a potential therapeutic
candidate can be evaluated directly with structural evi-
dence at nanometer resolution. For example, zinc ions and
extracellular calcium concentrations have been changed in
real time to prevent pathological amyloid beta-induced
changes in cellular morphology (ESM Fig. S7,r i g h t
panels).
A multimodal AFM combined with ﬂuorescence
microscopy can give valuable additional information and
conformation of processes observed with the AFM. For
instance, Calcein dye can be used to track neuronal death
and neurite arborization optically during AFM imaging
(ESM Fig. S7, left panel). Such optical techniques have
better temporal resolution since the AFM imaging of a
whole cell is time-consuming. Further developments in fast-
scanning AFM systems will be able to study such events
725 m-AFM: A Versatile Novel Technology for Nanopharmacology Researchwith sub-second time resolution, a large improvement over
the conventional AFM scans that take several minutes to
collect.
AFM to Assess Micro-rheological Properties
Fluid dynamics at tissue microcirculation, including ﬂuid
velocity, viscosity, shear stress, and shear rate, are important in
maintaining normal tissue function and in the pathogenesis of
vascular lesions like atherosclerosis, thrombosis, etc. Vascular
lesions affect the interaction of therapeutics with their targets
due to local alterations in the ﬂuid ﬂow, such as reduced ﬂow or
turbulence around a stenotic artery, occluded vein, or tumor
growth. Yet we know very little about them. It is difﬁcult to
measure ﬂuid viscosity with high precision in small volumes for
non-Newtonian ﬂuids like blood. Traditionally, ultrasonic
devices are used to measure viscosity (58). They operate at
megahertz frequency at which the viscosity of non-Newtonian
ﬂuids can be different as compared with low-frequency values,
which are of greater biomedical interest (59). Flexural-mode
resonance devices, such as microfabricated AFM cantilevers,
may be more reliable since they allow measurement at lower
frequencies. Using an optical detection in standard AFM
equipment, viscous drag was measured using a piezoelectric
actuator to vibrate an AFM silicon cantilever (60). Another
approach to the AFM measurement of liquid viscosity has been
theassessment of torsion inan AFM cantileverwhile scanninga
whisker tip inside the liquid (61). These techniques are
indispensable for assessing the effect of blood-thinning drugs
like aspirin, coumarin, heparin, dipyridamole, clopidogrel, etc.
and in the development of novel therapeutic agents with
potential effect on blood viscosity.
OUTLOOK
The salient features of the AFM have allowed us to see
beyond the limits of resolution thought possible only a few
years ago. We now have molecular and submolecular
resolution in physiologic environments; the ability to measure
incredibly small interactions, perhaps as small as the hydro-
gen bond; and a device that can be modiﬁed to allow the
identiﬁcation of speciﬁc structures and speciﬁc interactions,
such as ligand–receptor interactions; precise nanometer
control of the position and piconewton control of the canti-
lever that allows the physical manipulation of molecules, the
dissection of biological structure, the precise delivery of
ligands, drugs and materials, and even nanosynthesis.
The simple design and invariance to the operating
environment allows AFM to be integrated with other
techniques for simultaneous structure–function correlation
studies, such as the integration of the AFM with a ﬂuores-
cence microscope including confocal, TIRF, FRET modal-
ities, near-ﬁeld differential scanning optical microscope,
electro-optical manipulators, electrophysiologic recordings,
etc. These multidimensional and multimode AFM hold great
promise for the investigation of nanoscale structure and
function in complex biological systems. The AFM goes
beyond correlative studies. The functionalized AFM tip, for
example, allows the direct observation of ligand–receptor,
protein–protein, and other such interactions in physiological
solutions. Moreover, the ﬂexibility and high-resolution capa-
Fig. 5. Imaging of triple helical collagen I with AFM. The inset magniﬁes one collagen molecule. Bottom
panels Collagenase binding to collagen molecules. Images are taken before collagenase addition (a),
immediately after collagenase addition (b), and 4 min later (c). Globular particles bound to collagen are
indicated by arrows; thick arrows show sites where collagen was broken after collagenase binding. For
details, see Lin et al. (51)
726 Lal, Ramachandran and Arnsdorfbility of these integrated tools point toward a unique window
through which new and exciting information could be
harnessed about and from multiscale biological systems.
One exciting view through this new window has been the
discovery of a new type of toxic channel formed in protein-
misfolding diseases such as Alzheimer’s and other neurodege-
nerative diseases, diabetes, tuberculosis, etc. The next gener-
ation of AFMs will be faster and have softer imaging features
that would allow us not only to understand real-time conforma-
tional changes in nanoscale biological systems but would also
allow designing and fabricating such systems, the biomimetics.
In summary, AFM per se or m-AFM and AFM canti-
lever-based techniques offer a unique opportunity to probe
complex biological systems at single molecular level in their
native physiological conditions, which makes it a versatile and
indispensable tool in the advancement of nanopharmacology.
These current and future developments in AFM and its
growing application to biomedical and health research will be
at the forefront of nanomedicine, including nanodiagnostics,
nanotherapeutics, and the development of nanomedical
devices.
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